| APOE |
P02649
|
apolipoprotein E
|
|
1.9E-03 |
0.338 |
0.962 |
| BDNF |
P23560
|
brain derived neurotrophic factor
|
Signaling
|
0.66 |
0.345 |
0.923 |
| BRCA1 |
P38398
|
BRCA1 DNA repair associated
|
Enzyme
|
9.2E-29 |
0.367 |
0.923 |
| BRCA2 |
P51587
|
BRCA2 DNA repair associated
|
Nucleic acid binding
|
2.4E-25 |
0.379 |
0.846 |
| BRIP1 |
Q9BX63
|
BRCA1 interacting protein C-terminal helicase 1
|
Enzyme
|
6.2E-17 |
0.507 |
0.731 |
| CASP3 |
P42574
|
caspase 3
|
Enzyme
|
0.10 |
0.351 |
0.923 |
| CBS |
P0DN79 P35520
|
cystathionine beta-synthase
|
Enzyme
|
3.1E-05 |
0.465 |
0.885 |
| DLL4 |
Q9NR61
|
delta like canonical Notch ligand 4
|
|
1.00 |
0.494 |
0.769 |
| ERCC4 |
Q92889
|
ERCC excision repair 4, endonuclease catalytic subunit
|
Enzyme
|
1.4E-12 |
0.468 |
0.846 |
| FANCA |
O15360
|
FA complementation group A
|
|
1.6E-68 |
0.505 |
0.731 |
| FANCB |
Q8NB91
|
FA complementation group B
|
|
1.00 |
0.468 |
0.769 |
| FANCC |
Q00597
|
FA complementation group C
|
|
2.8E-13 |
0.507 |
0.808 |
| FANCD2 |
Q9BXW9
|
FA complementation group D2
|
|
1.1E-30 |
0.479 |
0.885 |
| FANCE |
Q9HB96
|
FA complementation group E
|
|
1.5E-06 |
0.553 |
0.808 |
| FANCF |
Q9NPI8
|
FA complementation group F
|
|
0.46 |
0.535 |
0.731 |
| FANCG |
O15287
|
FA complementation group G
|
|
2.5E-14 |
0.556 |
0.769 |
| FANCI |
Q9NVI1
|
FA complementation group I
|
|
8.9E-37 |
0.543 |
0.731 |
| FANCL |
Q9NW38
|
FA complementation group L
|
Enzyme
|
5.9E-23 |
0.551 |
0.731 |
| FANCM |
Q8IYD8
|
FA complementation group M
|
Enzyme
|
2.4E-15 |
0.543 |
0.731 |
| MAD2L2 |
Q9UI95
|
mitotic arrest deficient 2 like 2
|
|
8.2E-02 |
0.547 |
0.731 |
| MMP2 |
P08253
|
matrix metallopeptidase 2
|
Enzyme
|
0.84 |
0.333 |
0.923 |
| NOS3 |
P29474
|
nitric oxide synthase 3
|
|
6.7E-07 |
0.378 |
0.885 |
| PALB2 |
Q86YC2
|
partner and localizer of BRCA2
|
|
3.0E-19 |
0.485 |
0.769 |
| PCYT1A |
P49585
|
phosphate cytidylyltransferase 1, choline, alpha
|
|
2.0E-05 |
0.485 |
0.885 |
| RAD51 |
Q06609
|
RAD51 recombinase
|
|
2.7E-02 |
0.447 |
0.846 |